Exchange: NASDAQ·Updated 07:59 PM EDT
CNTX logo

CNTX Context Therapeutics Inc

$0.1891
$0.0126
(6.25%)
Today
Closed $0.1891
$0.0129
(6.82%)
After Hours
Mkt Cap$17.37M
Vol1.01M

About CNTX

Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. The firm's robust clinical program for candidate onapristone extended release (ONA-XR) comprises three Phase 2 clinical trials and one Phase 1b/2 clinical trial in hormone-driven breast, ovarian and endometrial cancer, as well as two Phase 0 biomarker pharmacodynamic trials in breast cancer. Its ONA-XR is a novel, first-in-class small molecule under development as a complete antagonist of the progesterone receptor, a key unchecked mechanism in hormone-driven women?s cancers. The company was founded by Martin Lehr and Felix Kim in April 2015 and is headquartered in Philadelphia, PA.
70

Bullish Sentiment

How do you feel about CNTX?

e999
$CNTX TCE has a very high potential for the future Stock prices are sad about this. I hope the company makes the public announcement and proceeds with the share buyback soon.
1
5
buymoremakemore
$CNTX I wonder which big pharma will want to get their hands on CTIM-76 when they report over 30% ORR and strong safety for late line PROC for a target with no approved therapies and 75% of PROC patients expressing CLDN6. 500M -750M BO for company not unreasonable for how much theyd make off CTIM-76 when approved. Not to mention a safe TCE for Nectin-4 with potentially an ORR in line with ADCs.
9
buymoremakemore
$CNTX a majority of traders will finish tax loss harvesting this week. Especially with midterms on deck. Good news in the Q3 ER PR can send this upward and break this downtrend Im optimistic one or both readouts will be good next year. Martin’s venture capital experience has already lended itself well to get funding. Like when they got 100M in PIPE 2 years ago without any clinical data and simply just an IND. Not to mention potentially more insider buying like they did last year between $0.50 - $0.70. Many ways to skin this cat
7
e999
$CNTX $CNTX CNTX has no rs history, and individuals have bought back shares multiple times. Also, the clinical results from similar companies are relatively good. cntx declined in June due to the small number of patients and samples, and on top of that, because they tried the high-risk group first, it ended up like this. It is not a clinical failure; two clinical trials are being conducted properly, and a clinical site has been added recently. Now, cntx needs to mention it directly!!!
7
buymoremakemore
$CNTX I look forward to 2 weeks when we get a much needed update on the trials in the Q3 earnings PR. This will make it a foregone conclusion that there is nothing wrong with the data thus far and that they will pursue a 180 day extension for Nasdaq compliance. The PR should be January that confirms the 180 day extension for nasdaq compliance, and it will go a long way for a data runup.
8
saad545
$CNTX No worries about delisting or dilution * company has till 27th of July 2027 to regain compliance. * Cash runway extended to Q4 2027 *Net Cash per share $.47 Correction will drive this up🔥
8
e999
$CNTX Can the PDSB case be compared with CNTX? It dropped to 0.2 at the time and then jumped above 1.5. They raised partnership funds at the time. CNTX's partnership is still in the early clinical stage, so it won't be easy, but wouldn't it be possible if a bit more early data comes out?
1
3
investhedge
$CNTX Eli Lilly very positive news from today, achieving 79% cORR and 100% DCR! In ovarian cancer treatment, great development news for industry! While it has not direct impact on CNTX, since we’re in a different sub area (CLDN6, Claudin 6) vs FRa that Lilly is targeting The industry is heating up , it’s a fact, and TCE should be a clear winner if things go well
6
claybridge
$CNTX MC down to $27M and trading well below cash. Trading as if the assets are near worthless. Insider buys would be good right about now.
6
SpencerF
$CNTX I wonder what the limits are to naked shorting. Could the big boys turn this down to 10 cents on Monday or do they kind of have to keep it gradual? Maybe they’ll shoot for New Year’s Eve to be the grand final zero out?
1
1
Wacala
$CNTX this was obtained from AI: "The key question now is whether CTIM-76 can reproduce its early results in more patients." I certainly think it can !!!!
5
Wacala
$CNTX Not too many people seem to comment in this site, wonder why? I hope I have not made a mistake to buy in right now!!! But after reading about it!!! It seems we have a very good chance to gain notice about their tail work is it will show significant progress.
5
SpencerF
$CNTX anything at all they could release before January 25th to turn things around? By then they would have to announce RS. Would imagine we’ll be around 18 cents by then. Mandatory 50% crash for announcing it taking it to 9 cents. Then it’s mandatory to have another 50% crash on the day of the reverse split which would get it to 4 cents. And that’s just if the hedgies don’t decide to help big pharma and just turn the price down to 0 manually as a favor…
1
2
SpencerF
$CNTX assuming big pharma ordered their hedge fund buddies to take this all the way to 0 in the name of keeping cancer around. Will naked shorting be able to fully zero it out? Or will the pesky cash at hand keep it a 5 cent stock for a while?
1
1
Wacala
$CNTX This is going to be a slow moving situation, but I just hope that as time progresses things improve, to at least get it over 1.00 before the middle of 2027.
4
Sanjaynaik2011
$CNTX IS THIS GARBAGE STILL IN THE MARKET? I THOUGHT THIS TRASH ALREADY GOT DELISTED OR IN OTC MARKET!! MAYBE SOON AFTER 1 REVERSE SPLIT OF 50 TO 1
1
1
claybridge
$CNTX brutal. Volume and candlesticks from the previous 3 trading sessions suggested a bottom, then bam...another leg down. They've got twice as much cash per share relative to market cap. Assets are worthless? Geeez...
2
LabPsycho
$CNTX Down ~90% in ~ 6 months - wow. Once these things start to crumble, in many cases, hanging on here leads to yet another 90% loss over the next 18 months. But who knows, could be like PDSB (doubt it as pdsb had good late stage data
2
investhedge
$CNTX brutal non stop selloff since June regardless of positive data reporting last June
2
LabPsycho
$CNTX I dont think so - PDSB has much more mature data from several programs. But...who knows...maybe CNTX will try similar move of a private placement / reverse merger

Advertisement|Remove ads.